Alexander Kertser

234 Herzl Street
Rehovot, M 76100, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer's disease: a phase 1b, randomized, double-blind trial.

Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer's disease: a phase 1b, randomized, double-blind trial.

Journal: Nature medicine

Published: May 27, 2026

Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.

Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.

Journal: Cell reports. Medicine

Published: May 17, 2023

Corticosteroid signaling at the brain-immune interface impedes coping with severe psychological stress.

Corticosteroid signaling at the brain-immune interface impedes coping with severe psychological stress.

Journal: Science advances

Published: September 13, 2018

Maternal Type-I interferon signaling adversely affects the microglia and the behavior of the offspring accompanied by increased sensitivity to stress.

Maternal Type-I interferon signaling adversely affects the microglia and the behavior of the offspring accompanied by increased sensitivity to stress.

Journal: Molecular psychiatry

Published: June 14, 2018

Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner.

Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner.

Journal: Nature communications

Published: October 15, 2016

PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease.

PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease.

Journal: Nature medicine

Published: October 12, 2015

Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology.

Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology.

Journal: Nature communications

Published: April 21, 2015

Cerebral nitric oxide represses choroid plexus NFκB-dependent gateway activity for leukocyte trafficking.

Cerebral nitric oxide represses choroid plexus NFκB-dependent gateway activity for leukocyte trafficking.

Journal: The EMBO journal

Published: October 29, 2014

Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function.

Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function.

Journal: Science (New York, N.Y.)

Published: August 23, 2014

IFN-γ-dependent activation of the brain's choroid plexus for CNS immune surveillance and repair.

IFN-γ-dependent activation of the brain's choroid plexus for CNS immune surveillance and repair.

Journal: Brain : a journal of neurology

Published: October 04, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026